Cogent Biosciences, Inc.

Contributing Author

Recent Articles by Cogent Biosciences, Inc.

Aug-26	Cogent Biosciences Announces Participation in the Citi Biopharma Conference COGT GlobeNewswire
Aug-05	Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2025 Financial Results COGT GlobeNewswire
Jul-10	Cogent Biosciences Announces Closing of Upsized Public Offering of Shares of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares COGT GlobeNewswire
Jul-08	Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock COGT GlobeNewswire
Jul-08	Cogent Biosciences Announces Proposed $150 Million Public Offering of Common Stock COGT GlobeNewswire
Jul-07	Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis COGT GlobeNewswire
Jun-11	Cogent Biosciences Secures up to $400 Million in Non-Dilutive Financing COGT GlobeNewswire
May-29	Cogent Biosciences Announces Participation in the Jefferies Global Healthcare Conference COGT GlobeNewswire
May-06	Cogent Biosciences Reports First Quarter 2025 Financial Results COGT GlobeNewswire